Best Practices on IRT and Clinical Supplies Management
IRT systems are critical to correct randomization and efficient drug supply management but too often they are an afterthought for a team juggling many conflicting priorities. With a little careful preparation, and an efficient internal process, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort.
- Appreciating the importance of IRT
- Understanding your own organization
- An analysis of previous approaches and the implications thereof
- Discussion of best practices
Kate Chapman, the Director of Clinical Technology Consultants Ltd and the Principal Consultant. Clinical Technology Consultants from Winchester,UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.